Innoviva, Inc. (INVA)
20.66
+0.04
(+0.19%)
USD |
NASDAQ |
Sep 11, 15:41
Innoviva Gross Profit (TTM) : 317.57M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 317.57M |
| March 31, 2026 | 310.07M |
| December 31, 2025 | 307.52M |
| September 30, 2025 | 309.98M |
| June 30, 2025 | 307.46M |
| March 31, 2025 | 309.31M |
| December 31, 2024 | 296.06M |
| September 30, 2024 | 284.13M |
| June 30, 2024 | 261.69M |
| March 31, 2024 | 243.76M |
| December 31, 2023 | 245.92M |
| September 30, 2023 | 231.91M |
| June 30, 2023 | 242.99M |
| March 31, 2023 | 284.04M |
| December 31, 2022 | 311.86M |
| September 30, 2022 | 367.40M |
| June 30, 2022 | 305.78M |
| March 31, 2022 | 197.69M |
| December 31, 2021 | 107.68M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -1.643M |
| September 30, 2014 | -1.643M |
| June 30, 2014 | -1.643M |
| March 31, 2014 | -1.643M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Zevra Therapeutics, Inc. | 128.53M |
| Collegium Pharmaceutical, Inc. | 485.09M |
| CorMedix, Inc. | 382.64M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |